Tag: FDA bioequivalence
Partial AUC in Bioequivalence: How Advanced Metrics Ensure Drug Safety and Efficacy
29 Jan
|
11:49 AM
Partial AUC is a precise pharmacokinetic tool used to assess bioequivalence in complex drug formulations. Unlike total AUC, it focuses on specific time windows critical for drug effectiveness and safety-especially for extended-release and abuse-deterrent products. Regulators like the FDA now require it for over 127 drug products.
read more
